Hu Brian, Satkunasivam Raj, Schuckman Anne, Sherrod Andy, Cai Jie, Miranda Gus, Daneshmand Siamak
Institute of Urology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Urol Oncol. 2014 Nov;32(8):1158-65. doi: 10.1016/j.urolonc.2014.08.004. Epub 2014 Sep 17.
The location of positive lymph nodes (LNs) is important for bladder cancer staging. Little is known regarding the impact of perivesical (PV) lymph node (PVLN) involvement on survival. This study characterized PVLN identified after radical cystectomy (RC) and analyzed their impact on recurrence and survival.
We reviewed our institutional review board-approved database including all patients who underwent RC with pelvic lymphadenectomy for curative intent for urothelial carcinoma. Clinical and pathologic data were obtained. Patients were analyzed in groups according to the location of positive LNs: PV+/other LN (ON)+, PV+/ON-, and PV-/ON+. Kaplan-Meier curves were used to estimate recurrence-free survival (RFS) and overall survival (OS). Multivariable Cox regression (including pathologic T category, number of positive LNs, highest level of positive LNs, chemotherapy, and margin status) was performed to evaluate associations between PVLN status and survival.
In total, 2,017 patients met inclusion criteria and 465 (23%) were LN+. PVLNs were identified in 936 patients (47%), positive in 197 patients (10%), and represented isolated LN+disease in 101 patients (5%). On univariate analysis, RFS and OS were significantly worse in the PV+/ON+group compared with the PV+/ON- and PV-/ON+ groups. There were no significant differences in RFS or OS between the PV+/ON- and PV-/ON+ groups. On multivariable analysis, PV+/ON+disease was independently associated with worse RFS and OS when compared with PV-/ON+ disease.
PVLNs were identified in a significant number of patients after RC. Positive PVLN, when in combination with other positive LNs, portends worse survival even when correcting for the number of positive nodes.
阳性淋巴结(LN)的位置对于膀胱癌分期很重要。关于膀胱周围(PV)淋巴结(PVLN)受累对生存的影响知之甚少。本研究对根治性膀胱切除术(RC)后识别出的PVLN进行了特征分析,并分析了它们对复发和生存的影响。
我们回顾了经机构审查委员会批准的数据库,该数据库包括所有因尿路上皮癌行根治性膀胱切除术及盆腔淋巴结清扫术以达到治愈目的的患者。获取了临床和病理数据。根据阳性LN的位置将患者分组分析:PV+/其他LN(ON)+、PV+/ON-和PV-/ON+。采用Kaplan-Meier曲线估计无复发生存期(RFS)和总生存期(OS)。进行多变量Cox回归分析(包括病理T分期、阳性LN数量、阳性LN最高水平、化疗和切缘状态)以评估PVLN状态与生存之间的关联。
共有2017例患者符合纳入标准,465例(23%)为LN阳性。936例患者(47%)识别出PVLN,其中197例(10%)为阳性,101例患者(5%)表现为孤立LN疾病。单因素分析显示,与PV+/ON-和PV-/ON+组相比,PV+/ON+组的RFS和OS显著更差。PV+/ON-组和PV-/ON+组之间的RFS或OS无显著差异。多变量分析显示,与PV-/ON+疾病相比,PV+/ON+疾病与更差的RFS和OS独立相关。
RC术后大量患者识别出PVLN。阳性PVLN与其他阳性LN并存时,即使校正阳性淋巴结数量,也预示着更差的生存。